Understanding the Colonic Transit Study (Sitz Markers)
Chronic constipation is a debilitating condition that affects millions of individuals globally. When lifestyle modifications, dietary fiber adjustments, and over-the-counter laxatives fail to provide relief, gastroenterologists and colorectal surgeons often require objective data to determine the underlying cause of bowel dysfunction. The Colonic Transit Study (CTS), specifically utilizing the Hinton method with radiopaque (Sitz) markers, remains the gold standard diagnostic tool for evaluating colonic motility.
This guide provides a comprehensive overview of the procedure, its clinical utility, and what patients and providers should expect during the diagnostic process.
Technical Specifications and Mechanisms
The Colonic Transit Study is a functional imaging procedure designed to measure the rate at which luminal contents move through the large intestine. Unlike colonoscopies, which visualize the anatomy of the bowel wall, the CTS evaluates the physiological performance of the colon.
The Hinton Method Explained
The Hinton method involves the ingestion of radiopaque markersโsmall, inert plastic rings or shapes that are visible on standard X-ray imaging. These markers are designed to move through the gastrointestinal tract at the same rate as solid fecal matter.
- Marker Composition: Usually consist of barium-impregnated polyethylene.
- The Procedure Cycle: A patient ingests a capsule containing a specific number of markers (typically 24).
- Imaging Schedule: An abdominal X-ray is performed at specific intervals, most commonly on Day 5 (120 hours post-ingestion). Some protocols utilize a multi-day approach (Days 1, 3, and 5) to determine if the transit delay is segmental or generalized.
Physics of Radiopacity
The markers are constructed with high atomic number materials (barium compounds), which attenuate X-ray beams significantly more than soft tissues. This creates high-contrast, distinct images on the resulting radiographs, allowing the radiologist to count the remaining markers with high precision.
Clinical Indications and Usage
The Colonic Transit Study is indicated for patients presenting with chronic, idiopathic constipation that is refractory to standard medical management. It is primarily used to differentiate between functional constipation subtypes.
When is a CTS Ordered?
- Chronic Constipation: Persistent symptoms exceeding 6-12 months.
- Suspected Slow Transit Constipation (STC): Where the colon fails to move waste at a normal physiological rate.
- Pelvic Floor Dysfunction: Suspected dyssynergic defecation, where markers accumulate in the rectosigmoid colon.
- Pre-Surgical Evaluation: Before considering a subtotal colectomy, surgeons must confirm that the colon is indeed the source of the delay.
Differential Diagnosis Table
| Condition | Marker Distribution Pattern |
|---|---|
| Normal Transit | Markers are evenly distributed or mostly excreted. |
| Slow Transit (STC) | Markers are scattered throughout the colon, indicating global delay. |
| Outlet Obstruction | Excessive markers clustered in the rectosigmoid area. |
Patient Preparation and Procedure Steps
Proper preparation is essential to ensure the accuracy of the study and to avoid the need for repeat testing.
Pre-Procedure Instructions
- Medication Washout: Patients must discontinue all laxatives, stool softeners, prokinetics, and enemas for at least 3 to 5 days prior to the study.
- Dietary Fiber: Maintain a consistent diet; avoid sudden changes or high-fiber supplements that could artificially accelerate transit.
- Pregnancy Screening: Due to the use of ionizing radiation, female patients of childbearing age must confirm they are not pregnant.
The Procedure Workflow
- Day 0: The patient ingests the capsule containing the radiopaque markers with a glass of water.
- The Waiting Period: The patient resumes a normal diet but avoids any bowel-stimulating medications.
- Day 5 (The Imaging Day): The patient returns to the radiology department for a single abdominal X-ray (KUB - Kidneys, Ureters, and Bladder).
- Data Analysis: The radiologist counts the markers remaining in the colon and compares them against standardized norms.
Risks, Radiation, and Contraindications
Radiation Exposure
The CTS involves a low dose of ionizing radiation. A single abdominal X-ray provides approximately 0.7 mSv of radiation. To put this in perspective, this is roughly equivalent to 3-4 months of natural background radiation exposure. While the risk is minimal, the procedure is avoided in pregnant women unless absolutely necessary.
Contraindications
- Pregnancy: Primary absolute contraindication due to fetal radiation risk.
- Bowel Obstruction: If a mechanical obstruction is suspected, the ingestion of markers is contraindicated as it could complicate the obstruction.
- Acute Abdomen: Severe abdominal pain or signs of perforation.
Interpretation of Results
The interpretation is based on the total number of markers retained after 120 hours.
- Normal Result: Retention of less than 20% of the markers (fewer than 5 markers) is typically considered normal.
- Abnormal Result (Slow Transit): Retention of more than 20% of markers scattered throughout the colon suggests colonic inertia or slow transit constipation.
- Abnormal Result (Outlet Obstruction): Retention of markers in the distal colon (rectum/sigmoid) suggests a failure of the pelvic floor muscles to coordinate properly during evacuation.
Frequently Asked Questions (FAQ)
1. Is the Colonic Transit Study painful?
No, the procedure is non-invasive and painless. It involves simply swallowing a capsule and undergoing a standard X-ray.
2. Can I eat normally during the study?
Yes, you are encouraged to maintain your normal diet so that the study accurately reflects your typical bowel function.
3. How much radiation will I be exposed to?
The radiation dose is very low (approx. 0.7 mSv), which is considered safe for the vast majority of patients.
4. What happens if I miss a day of the study?
If the imaging is not performed on the correct day, the results may be invalid. It is crucial to adhere to the schedule provided by your clinic.
5. Will the markers pass in my stool?
Yes, the markers are inert and will eventually be passed in your stool. You may not notice them, as they are very small.
6. Do I need to be sedated?
No sedation is required for this study.
7. What is the difference between this and a colonoscopy?
A colonoscopy looks at the lining of the colon for polyps or inflammation. A CTS looks at how fast food moves through the colon.
8. Is this test covered by insurance?
Most insurance plans cover the CTS when it is deemed medically necessary for chronic constipation, but you should check with your provider beforehand.
9. What should I do if the test is positive for slow transit?
Your doctor will likely discuss treatment options, which may include prescription prokinetic agents, pelvic floor physical therapy, or, in rare cases, surgical consultation.
10. Can children have this test?
Yes, pediatric versions of the test exist, though the number of markers and the protocol may be adjusted by a pediatric gastroenterologist.
Conclusion
The Colonic Transit Study remains a cornerstone of gastroenterological diagnostics. By providing a clear, quantifiable measure of colonic motility, it allows clinicians to move beyond trial-and-error treatments and toward evidence-based management of chronic constipation. If you are struggling with persistent bowel issues, consult with your healthcare provider to determine if a Sitz marker study is the appropriate next step in your diagnostic journey.